Anger over NICE colon cancer drug verdict

Charities have reacted angrily to the decision by the National Institute for Health and Clinical Excellence not to recommend the use of two colon cancer drugs.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here